AI assistant
Sending…
RESMED INC — Director's Dealing 2021
Jan 5, 2021
30071_dirs_2021-01-05_652e31f0-1f00-48ef-9b47-ebd509b7d96c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-01-04
Reporting Person: Hollingshead James (President, Sleep Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-04 | ResMed Common Stock | S | 2400 | $211.089 | Disposed | 88333 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29